Search

everythinglearnresearchcommunity

for

Search:↓

About 2.2% of women with symptoms of high male hormones have a mild form of congenital adrenal hyperplasia, and measuring a specific hormone level can accurately diagnose it.

Patients with PCOS rate their hirsutism higher than clinicians, and these self-ratings are more closely related to their quality of life and risk of depression.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

High BMI worsens hair growth in women with PCOS.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

Many young women who donate blood have hormonal disorders like excess male hormones and PCOS.

DNA methylation changes in women with PCOS could be used as disease markers and suggest new treatment targets.

A young woman with kidney failure had hair loss due to a common hormonal disorder, which improved with hormone therapy.

Normal-range ALT levels can indicate metabolic and hormonal imbalances in young women.

Insulin resistance is not more common in idiopathic hirsutism patients than in healthy individuals.

The research suggests that the global distribution of PCOS is likely due to historical human migration and that genes affecting PCOS may have different impacts on males and females.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Lipocalin-2 levels are higher in women with PCOS and may indicate insulin resistance.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

Women with PCOS have more severe liver disease.

Blood tests are needed to confirm high male hormone levels in women with PCOS, as physical signs alone are not reliable.

Women with PCOS are more likely to have impaired glucose tolerance and type 2 diabetes, especially if they are Asian or obese.

Most patients with PCOS were prescribed medroxyprogesterone acetate or oral contraceptives, with some experiencing side effects or needing prescription changes.

Evaluate postmenopausal women with high androgen levels using medical history, physical exams, lab tests, and imaging to manage health risks.

Skin problems in patients with polycystic ovarian disease are linked to body weight, blood sugar, and hormone levels.

Women with PCOS tend to have higher anxiety and depression levels compared to healthy women.

Women with Polycystic Ovary Syndrome are more likely to have Non-Alcoholic Fatty Pancreas Disease, which is associated with older age, metabolic syndrome, insulin resistance, and high male hormone levels.

Most hirsutism patients had idiopathic hirsutism or PCOS, with hormonal imbalances and signs like acne and irregular periods.

Caucasian and Asian women with PCOS generally show similar symptoms, except Asian women have less chest hair.

Women with PCOS have lower amylin levels, which are not related to their body weight.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Women with Polycystic Ovary Syndrome (PCOS) have lower levels of a substance called DIAPH1 in their blood, which is linked to changes in sugar metabolism and insulin resistance.

Some skin conditions may increase the risk of heart disease, but are not yet included in cardiovascular prevention guidelines.

Turkish women with hirsutism experience lower quality of life, especially those with PCOS, regardless of hair growth severity.